Table 2.
Crude | Age-adjusteda | Age, sex ajusteda | No. individualsb | ||||||
---|---|---|---|---|---|---|---|---|---|
PP | PE | 95 CI | PP | 95 CI | PP | 95 CI | Count | 95 CI | |
CI (Dementia+ CIND) | |||||||||
Male | 14/116 | 12,1 | 6,1 18,0 | 10,7 | 4,6-16,9 | ||||
Female | 48/211 | 22,7 | 17,1-28,4 | 19,1 | 12,9-25,2 | ||||
Both | 62/327 | 19,0 | 14,7-23,2 | 16,1 | 11,6-20,6 | 14,9 | 10,6-19,2 | 51 | 36-65 |
Age-group | |||||||||
65-69 | 9/69 | 13,0 | 5,1-21,0 | ||||||
70-74 | 8/72 | 11,1 | 3,9-18,4 | ||||||
75-79 | 9/75 | 12,0 | 4,6-19,4 | ||||||
80-84 | 15/63 | 23,8 | 13,3-34,3 | ||||||
≥ 85 | 21/48 | 43,8 | 29,7-57,8 | ||||||
CIND | |||||||||
Male | 10/116 | 8,6 | 3,5 - 13,7 | 8,1 | 2,5-13,6 | ||||
Female | 38/211 | 18,0 | 12,8 - 23,2 | 15,1 | 9,6-20,6 | ||||
Both | 48/327 | 14,7 | 10,8 - 18,5 | 11,4 | 7,5-15,4 | 11,6 | 7,7-15,5 | 39 | 26-53 |
Age-group | |||||||||
65-69 | 8/69 | 11,6 | 4,0-19,1 | ||||||
70-74 | 7/72 | 9,7 | 2,9-16,6 | ||||||
75-79 | 3/75 | 4,0 | 0,0-8,4 | ||||||
80-84 | 12/63 | 19,0 | 9,4-28,7 | ||||||
≥ 85 | 11/48 | 22,9 | 11,0-34,8 | ||||||
Dementia | |||||||||
Male | 4/116 | 3,4 | 0,1 - 6,8 | 2,7 | 0,0 - 5,3 | ||||
Female | 10/211 | 4,7 | 1,9 - 7,6 | 4,0 | 1,3 - 6,8 | ||||
Both | 14/327 | 4,3 | 2,1 - 6,5 | 3,4 | 1,5 - 5,3 | 3,3 | 1,4 - 5,2 | 11 | 5-18 |
Age-group | |||||||||
65-69 | 1/69 | 1,4 | 0,0 - 4,3 | ||||||
70-74 | 1/72 | 1,4 | 0,0 - 4,1 | ||||||
75-79 | 6/75 | 8,0 | 1,9 - 14,1 | ||||||
80-84 | 3/63 | 4,8 | 0,0 - 10,0 | ||||||
≥ 85 | 3/48 | 6,3 | 0,0 - 13,1 |
aAge standardization weights European Standard: 36.4, 27.3, 18.2, 9.1 and 9.1 for 65-69, 70-74, 75-79, 80-84 and ≥85, respectively; sex standardization weight: 0.50 (sources: http://www.wmpho.org.uk/localprofiles/metadata.aspx?id=META_EUROSTD) [26];
bEstimated number of subjects in hundreds with de disease based on age- and sex-adjusted prevalence (Salamanca h ≥65 years 2009 estimated population: 34.020h. (source: Castilla and León Regional Health Service lists. CIND: cognitive impairment not dementia; CI, confidence interval; PE, prevalence point-estimate; PP, crude prevalence ratio (cases divided by population).